Currently Funded Research
Dr Neil Rajan,
Newcastle University, UK
Delineating the Cutaneous Tumour Microenvironment in Birt-Hogg-Dubé Syndrome
Learn more about Neil’s research project here.
Dr Arjan Houweling,
Amsterdam UMC, The Netherlands
Improving Care for Birt-Hogg-Dubé Syndrome Patients: Clinical and Genetic Analysis of a Unique Cohort
Learn more about Arjan’s research project here.
Professor Stefan Marciniak,
University of Cambridge, UK
Determining the Prevalence of Pathogenic FLCN Variants from Large Genomic Registries
Learn more about Stefan’s research project here.
Professor Mark Lowdell,
Assessment of Human NK Cell Responses and Potentiation in Patients with Renal Cell Cancer – Pre-clinical Study to Support a Phase 2a Clinical Trial
Learn more about Mark’s research project here.
Professor Masaya Baba,
Kumamoto University, Japan
CRISPR/Cas9 Mediated Unbiased Genome Wide Screening to Target both Tumour Cell Autonomous and Tumour Microenvironmental Factors in FLCN Deficient RCC Cells
Learn more about Masaya’s research project here.
Dr Fulya Taylan,
Karolinska Institute, Sweden
Investigating Molecular Mechanisms of an Autosomal Recessive FLCN-related Disorder Resembling Biallelic FNIP1 Disorder
Learn more about Fulya’s research project here.
Dr Wolfgang Paster,
Children’s Cancer Research Institute, Vienna, Austria
The Immunopeptidome of Paediatric High-Grade Osteosarcoma
Learn more about Wolfgang’s research project here.
Professor Nancy DeMore,
Medical University of South Carolina, USA
Combination Therapy with a Humanized Monoclonal Antibody to Secreted Frizzled Related Protein 2 for Metastatic Osteosarcoma
Learn more about Nancy’s research project here.
Professor Graham Cook and Dr Fiona Errington-Mais,
University of Leeds, UK
Oncolytic Virus-based Activation of Natural Killer Cells for the Immunotherapy of Osteosarcoma
Learn more about Graham and Fiona’s research project here.